The mononuclear phagocyte system regulates tissue homeostasis as well as all phases of tissue injury and repair. To do so changing tissue environments alter the phenotype of tissue macrophages to assure their support for sustaining and amplifying their respective surrounding environment. Interferon-regulatory factors are intracellular signaling elements that determine the maturation and gene transcription of leukocytes. Here we discuss how several among the 9 interferon-regulatory factors contribute to macrophage polarization.
1. Introduction
During development mononuclear phagocyte progenitors populate most tissues where they differentiate into transcriptionally and functionally diverse phenotypes [1–3]; for example, bone marrow, liver, and lung harbor macrophages with an enormous capacity to clear airborne particles, gut-derived pathogens, or cell nuclei expelled from erythroblasts, respectively [4]. In contrast, skin, kidney, and brain host a dense network of dendritic cells [4, 5]. Upon tissue injury M-CSF drives resident mononuclear phagocyte to proliferate [6] or circulating monocytes recruit to the site of injury. It is the local microenvironment that then determines mononuclear phagocyte polarization to distinct phenotypes, which can vary between disorders or between the different stages of a disease process [7]. Several factors mediate mononuclear phagocyte polarization, as being mostly described by in vitro experiments [7, 8]. However, attempts to translate this simplistic model to disease states in vivo often failed to cover all aspects of heterogeneous and changing tissue environments. For example, ischemia-reperfusion injury induces transient sterile inflammation because dying tissue cells release damage-associated molecular patterns (DAMPs) that polarize macrophages toward a classically activated M1-like phenotype [9, 10]. This process is associated with NF-κB and STAT1 pathway activation [2]. Macrophages apoptosis or their phenotype switches towards alternatively activated, M2-like macrophages that produce IL-10 and TGF-β, induce resolution of inflammation, and enforce tissue regeneration [11–15]. Failure of this phenotype switch leads to persistent tissue inflammation, atrophy, and fibrosis [16]. The uptake of neutrophils, epithelium-derived alarmins, and Th2 cytokines IL-4 and IL-13 supports this phenotype switch [11]. As disease processes do not always occur in a serial manner, concomitant proinflammatory and anti-inflammatory macrophages infiltrates often populate organs affected by persistent injury, for example, in slowly progressive lesions of organ transplants [17, 18].
Current data suggest that the family of the interferon-regulatory factors (IRFs) plays an important role in regulating macrophage polarization. IRFs are intracellular proteins that regulate immune cell maturation [19]. Here we provide a summary on IRF biology that is focused on the IRF’s role in macrophage phenotype control and the associated contributions to tissue inflammation and remodeling.
2. The Family of Interferon-Regulatory Factors
The IRFs were discovered in search of transcription factors that bind to the conserved virus response elements within the promoters of type I IFN genes [19]. It was found that both NF-κB and IRF-3 activate IFN-β gene transcription while IFN-α gene expression is entirely based on IRFs [19]. The generation of Irf-deficient mice led to the discovery of additional regulatory roles of the IRFs for cell growth, for immune cell maturation and activation, and for apoptosis. In mammals the IRF gene family consists of nine members: IRF-1, IRF-2, IRF-3, IRF-4, IRF-5, IRF-6, IRF-7, IRF-8/ICSBP, and IRF-9. Their respective IRF proteins share significant homologies at the N-terminal 115 amino acids where they share a conserved tryptophan pentad repeat DNA-binding domain [20]. These include a DNA-binding domain of five tryptophan repeats of which three recognize the GAAA and AANNNGAA sequence motifs, that is, the IFN-stimulated response elements [20]. However, the variable domains at the C-terminus determine the functional specificity of the nine IRFs, their potential to interact with each other via IRF-association domains, and their cell type-specific actions [21] (Figure 1). Accordingly, the IRFs have been subdivided into the “interferonic” IRFs (IRF-2, -3, -7, and -9), the “stress-responsive” IRFs (IRF-1 and -5), the “hematopoietic” IRFs (IRF-4 and -8), and the “morphogenic” IRF-6 [22]. The genetic and biological characteristics of the IRF family members are listed in Table 1.
Interferon-regulator factors and macrophage polarization.
Chromosome
Expression
Effect on macrophages
Favoured macrophage phenotype
IRF-1
5q31
Ubiquitous
Induced by IFN-γ, mediates TLR/MyD88 signaling, interacts with NF-κB (“enhanceosome”), and suppresses IL-4 promotor
M1
IRF-2
4q34
Ubiquitous
Suppression of IRF-1-mediated IFN and Cox-2 induction, complex role in LPS-induced cytokine release, and suppression of STAT1/3 signalling
Structural domain organization and important posttranslational modifications of IRFs. Proteins are illustrated by N-terminus on the left and C-terminus on the right. Each of the nine IRFs consists of a conserved pentad repeat DNA-binding domain. Regulatory and repression domains are mostly located in the C-terminal domain. IRF-association domains 1/2(IADs) mediate the interaction with other IRF-family members. Yellow arrows indicate the phosphorylation site within the domain. Posttranslational modifications are illustrated in the right column. Numbers of amino acids for each IRF are given next to structural scheme.
3. IRFs in Macrophage Polarization3.1. IRF-1
IRF-1 was first described in 1980s as a 325-amino acid-long nonredundant transcription factor for type I IFNs upon TLR3 ligation [23–25]. IRF-1 is only weakly expressed in resting DCs and macrophages but is induced by IFN-γ up to 8-fold in M1 polarized macrophages [26]. IRF-1 interacts with MyD88 to migrate into the nucleus where it triggers TLR-mediated expression of proinflammatory genes [27, 28]. Casein kinase II activates IRF-1 by phosphorylation [29]. The protein complex formed by IRF-1, NF-κB, and Jun that bind to the IFN-β promotor was named “enhanceosome” [28, 30–32]. Sumoylation represses the transcriptional activity of IRF-1 [33]. LPS challenge requires IRF-1 to induce TLR3, TLR6, and TLR9 in macrophages [34]. In fact, Irf1-deficient macrophages almost entirely lack inducible nitric oxide synthase (iNOS) production upon LPS and IFN-γ stimulation [35]. This way, IRF-1 contributes to the priming of classically activated, M1-like macrophage polarization in inflammatory tissue environments that involve IFN-γ-producing NKT cells or Th1 T cells [36]. At the same time, IRF-1 suppresses the binding of other transcription factors to the IL-4 promoter, which inhibits alternative macrophage activation [37]. This process supports host defense against intracellular pathogens but also accounts for M1 macrophage-related immunopathology [35, 36, 38]. The latter is particularly evident in sterile inflammation, for example, in ischemia-reperfusion injury [39, 40].
3.2. IRF-2
IRF-2 is 349-amino acid-long and displays considerable sequence homology with IRF-1 [23]. IRF-2 competes with IRF-1 for the same cis-acting recognition sequences in gene promoters [41]. Hence, IRF-2 is a negative regulator of IRF-1-mediated type I IFN and Cox-2 induction [23, 31]. IRF-2 has a more complex role in cytokine regulation as it suppresses LPS-induced TNF expression while augmenting LPS-induced IL-1, IL-6, IL-12, and IFN-γ secretion [42]. Sumoylation increases IRF-2’s ability to inhibit IRF-1 transcriptional activity [43]. LPS challenge regulates TLR3, TLR4, and TLR5 via IRF-2 in macrophages [34]. IRF-2 suppresses caspase-1-mediated programmed cell death by interfering with the transcriptional regulation of caspase-1 and by suppressing STAT1/3 signaling [44]. Irf-2-deficient mice are highly susceptible to Listeria monocytogenes infection, which seems to be related to IRF-2’s role in mediating the IFN-γ-induced oxidative burst that kills the pathogen inside intracellular compartments of macrophages [45]. However, this was iNOS transcription independent. IRF-2 rather regulates iNOS in a posttranscriptional manner [46]. The net effect of IRF-2 on sterile inflammation seems to be immunosuppressive as Irf-2-deficient mice are more susceptible to lymphocytic choriomeningitis virus infection as well as to ischemia-reperfusion injury-related tissue inflammation while that latter was suppressed in mice that overexpress IRF-2 [47]. IRF-2’s negative regulatory effect on type I IFN expression also suppresses inflammatory skin disease involving CD8 T cells [48]. In addition, IRF-2 is needed for the development of splenic and epidermal CD4+ dendritic cells [49].
3.3. IRF-3
IRF-3 was discovered by searching genes with homology sequences with IRF-1 and IRF-2 [50]. This 427-amino acid protein shares a number of characteristics with IRF-7 [51]. Unlike IRF-7, that confers MyD88 signaling, IRF-3 is involved in TRIF-dependent signaling pathways. After binding pathogens, pattern-recognition receptors like TLR-3, TLR-4, or RIG-I recruit TRIF to trigger an IRF-3-mediated induction of type I IFNs [52–55]. Additional cytoplasmic DNA recognition receptors use the STING pathway to activate IRF-3 [56]. The transcriptional activation of the IFN-β gene requires an enhanceosome of 7 additional proteins that create a continuous surface that recognizes the DNA-binding element [57]. Phosphorylation of TLR3’s specific tyrosine residues can initiate two distinct signaling pathways. One activates TBK-1 and the other activates PI3 kinase and Akt for full phosphorylation and activation of IRF-3 [58, 59]. Cytoplasmic IRF-3 is inactive unless phosphoactivation of IRF-3 triggers unfolding of the autoinhibitory elements and exposes the hydrophobic surface to interaction with CREBBP to translocate to the nucleus [60]. By contrast, ubiquitination inactivates IRF-3 [61]. GM-CSF-primed M1-like macrophages display a diminished IRF-3 axis and enhanced activation of MyD88. In contrast, M-CSF stimulated macrophages that develop an M2-like phenotype show defective NF-κB activation and enhanced TRIF-mediated IRF-3 induction upon LPS stimulation [62, 63]. Hence, the IRF-3 axis is rather enabled in M2-like macrophages than in M1-like macrophages. But does IRF-3 also contribute to the development of an alternatively activated macrophage phenotype? One study transduced IRF-3 into primary human microglia. Stimulation with IFN-γ/IL-1 suppressed proinflammatory mediators like IL-6, TNF-α, or IL-1β, whereas anti-inflammatory mediators including IL-10 were enhanced [64]. Altogether the data suggest that IRF-3 is associated with anti-inflammatory microenvironments and contributes to the polarization toward a M2 macrophage phenotype. However, IRF-3 also induces a number of inflammatory cytokines such as CCL5 and IFN-β [65].
3.4. IRF-4
IRF-4, first described in 1995, is a 450-amino acid-long “hematopoietic” protein with considerable homology with IRF-1 and IRF-2 [66]. IRF-4 contributes to the maturation of multiple myeloid and lymphoid cell types from their lineage-specific progenitors [19, 67]. IRF-4 competes with IRF-5 for binding to the adaptor MyD88 that transmits TLR outside-in signaling to NF-κB and other proinflammatory transcription factors [27]. As IRF-5 is needed for signal transduction the competitive action of IRF-4 for MyD88 binding renders IRF-4 an endogenous TLR signaling antagonist that can suppress M1 macrophage polarization [68]. IL-10 induction needs IRF-4 and IRF-4 overexpression enhances IL-4 and IL-10 secretion [69]. On the contrary, IRF-4−/− mice are more sensitive to LPS-induced sepsis and exhibit higher production of proinflammatory cytokines like TNF and IL-6 [70]. IL-4 induces macrophages to upregulate IRF-4 and contributes to their M2 polarization [71]. Accordingly, IRF-4 deficiency leads to decreased expression of M2 marker genes like Arg1, Ym1, and Fizz1 [72]. In fact, Jumonji domain-containing-3 (Jmjd3), a histone 3 Lys27 (3K27) demethylase, regulates the trimethylation at H3K27 of a selected number of genes including IRF-4. This mechanism controls IRF-4 induction and is needed for M2 macrophage polarization, for example, in the host defense during helminth infection [72]. Interestingly, IL-4-induced STAT6 signaling regulates Jmjd3 [73]. Hence, polarization of alternatively activated macrophages through IL-4 seems to be mediated via STAT6-Jmjd3-IRF-4 signaling and reveals an essential role of IRF-4 in macrophage polarization for helminth control.
3.5. IRF-5
IRF-5 is a 504-amino acid-long stress-responsive IRF [22]. IRF-5 is required for TLR-mediated induction of IL-6, TNF, IL-12, and other proinflammatory cytokines [74]. IRF-5 competes with IRF-4 for binding to the signaling adapter MyD88 and the downstream subsequent activation of proinflammatory transcription factors [27]. Its capacity to induce inflammatory cytokines and B cell transcription factors implies its role in host defense and autoimmune disorders [75, 76]. This competitive interaction involves IRF-5 in the polarization into M1 macrophages [68]. In fact, the balance between IRF-4 and IRF-5 seems to be a major determinant of M1 versus M2 macrophage polarization. For example, M-CSF induces IRF-4 in human monocyte-derived macrophages while GM-CSF induces IRF-5, which results in two phenotypically different macrophage phenotypes [77]. M1 macrophages express high levels of IRF-5 where it not only mediates the expression of proinflammatory cytokines but also suppresses the immunoregulatory cytokine IL-10 [68]. IRF-5 itself is regulated by the transcriptional corepressor KAP1/TRIM28 to avoid overshooting secretion of TNF and other mediators that induce immunopathology [78]. KAP1/TRIM28 regulates IRF-5 by recruiting histone deacetylases and methyltransferases that can silence IRF-5-related gene expression [78]. IRF-5-mediated polarization of monocytic phagocytes involves the secretion of various IL-12 family members including IL-12p35 and IL-23p19, which support Th17 T cell immunity, an element of adaptive immunity that contributes to autoimmune disorders [79]. In fact, gain of function mutations in the IRF-5 gene exists that increases TLR- or NOD-mediated secretion of proinflammatory cytokines [80]. Such variants also predispose to autoimmune diseases like systemic lupus erythematous [81–83], which may be related to these phenomena.
3.6. IRF-6
IRF-6 is a so-called “morphogenic” IRF of 467 amino acid length. IRF-6 has a large structural homology with IRF-5 but does not seem to share its functional properties or contribute to macrophage biology, which is related to the tissue-specific expression of IRF-6. IRF-6 mutations rather predispose to cleft lip or palate and other abnormalities of limb, skin, and craniofacial morphogenesis [84, 85].
3.7. IRF-7
IRF-7, together with IRF-3, is a 503-amino acid central and nonredundant mediator of viral nucleic acid-induced induction of IFN-α [19, 86, 87]. IRF-7 drives the differentiation of monocytes to macrophages but a direct role in macrophage polarization has not been reported.
3.8. IRF-8
IRF-8, also known as interferon consensus sequence-binding protein (ICSBP), is a 393-amino acid-long “hematopoietic” IRF [22]. IRF-8 (like IRF-4) has a dominant role in the maturation and differentiation of monocytes and macrophages from their immature progenitors, while it represses neutrophil production [88–90]. IFN-γand LPS slow down the intrinsic mobility of IRF8 inside the nucleus to enforce its chromatin interaction for the initiation of transcription [91]. IFN-γinduces IRF-8 and IRF-8 drives to induction of IFN-β, IL-12p40, IL-12p35, and iNOS upon TLR stimulation, that is, M1 macrophage gene profile [92]. In addition, IRF-8 integrates outside-in signaling of Notch receptors and TLRs for the induction of genes that define an M1 macrophage phenotype [93]. IRF-8 selectively modulates TLR4 signaling via IRAK2-dependent activation of MNK1 and eIF4E-regulated translation. IRF-8 itself is regulated by small ubiquitin-like modifiers (SUMO) 2/3 at the lysine residue 310. SUMO3-conjugated IRF8 cannot induce IRF-8 target genes [94]. Upon macrophage activation, SUMOylation of IRF-8 is reduced as the deSUMOylating enzyme, sentrin-specific peptidase 1 (SENP1), inactivates SUMOylation-related IRF-8 repression. As such IRF-8 SUMO conjugation/deconjugation represents a previously unrecognized mechanism of macrophage phenotype control.
3.9. IRF-9
IRF-9 is a 424-amino acid-long regulator of type I IFN signaling. It forms a DNA-binding complex with the STAT1 homodimer, for example, for the induction of CXCL10 [95]. A specific role in macrophage polarization has not been reported.
4. Summary and Perspective
Macrophages contribute to tissue homeostasis and all phases of tissue injury and repair. Tissue environments prime macrophages to distinct phenotypes to assure that their functional properties enforce the surrounding environment, whether this may be inflammation, the resolution of inflammation, tissue repair (fibrosis), or the resolution of extracellular matrix. Members of the IRF family are an integral component of the macrophage polarization process and, hence, regulate the phenotypic plasticity and heterogeneity of tissue macrophages. Research in this area is still in progress, but our present working model refers to IRF-1, IRF-5, and IRF8 as factors driving the proinflammatory, classically activated (M1) macrophage phenotype, while IRF-3 and IRF-4 promote anti-inflammatory, alternatively activated (M2) macrophages (Figure 2). Future work in this area will certainly refine this concept and define additional functions of the IRF’s in this context and elucidate additional mechanisms of how changing tissue environments shape immune effector cells to meet the tissue needs in homeostasis and disease.
Working model of the role of interferon-regulatory factors in macrophage polarization. Circulating monocytes reach tissues by rolling and adhesion at luminal surfaces of activated endothelia, which is followed by transmigration into the interstitial tissue compartment. The local environment will prime M0 macrophage polarization, a process to which interferon-regulatory factors (IRFs) contribute in a phenotype-specific manner. See text for details.
AbbreviationsCCL:
Chemokine ligand
CCR:
Chemokine receptor
Cox-2:
Cyclooxygenase 2
CREBBP:
CREB-binding protein
DAMP:
Danger-associated molecular pattern
eIF4E:
Eukaryotic translation initiation factor 4E
GM-CSF:
Granulocyte-macrophage colony-stimulating factor
IFN:
Interferon
iNOS:
Inducible nitric oxide synthase
IRF:
Interferon-regulatory factor
Jmjd3:
Jumonji domain-containing-3
KAP1:
KRAB-associated protein-1
M-CSF:
Macrophage colony-stimulating factor
MNK1:
MAPK signal-integrating kinase 1
NO:
Nitric oxide
NOD:
Nucleotide-binding oligomerization domain-containing protein
All authors do not have competing interests and do not have a financial relation to profiting companies or commercial products.
Acknowledgments
Hans-Joachim Anders was supported by the Deutsche Forschungsgemeinschaft AN371/15-1 and GRK1202. Roman Günthner was supported by the GRK1202.
GeissmannF.ManzM. G.JungS.SiewekeM. H.MeradM.LeyK.Development of monocytes, macrophages, and dendritic cells201032759666566612-s2.0-7624909516910.1126/science.1178331GordonS.TaylorP. R.Monocyte and macrophage heterogeneity20055129539642-s2.0-2854444611110.1038/nri1733GautierE. L.ShayT.MillerJ.Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages2012131111181128WynnT. A.ChawlaA.PollardJ. W.Macrophage biology in development, homeostasis and disease20134967446445455SoosT. J.SimsT. N.BarisoniL.LinK.LittmanD. R.DustinM. L.NelsonP. J.CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney20067035915962-s2.0-3374648268010.1038/sj.ki.5001567JenkinsS. J.RuckerlD.CookP. C.JonesL. H.FinkelmanF. D.Van RooijenN.MacDonaldA. S.AllenJ. E.Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation20113326035128412882-s2.0-7995871522910.1126/science.1204351MurrayP. J.WynnT. A.Protective and pathogenic functions of macrophage subsets201111117237372-s2.0-8035513197610.1038/nri3073SicaA.MantovaniA.Macrophage plasticity and polarization: in vivo veritas201212237877952-s2.0-8485788384710.1172/JCI59643RockK. L.LatzE.OntiverosF.KonoH.The sterile inflammatory response2010283213422-s2.0-7795229460910.1146/annurev-immunol-030409-101311SwaminathanS.GriffinM. D.First responders: understanding monocyte-lineage traffic in the acutely injured kidney20087412150915112-s2.0-5704912506010.1038/ki.2008.555GordonS.Alternative activation of macrophages20033123352-s2.0-003726524010.1038/nri978AndersH.-J.RyuM.Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis20118099159252-s2.0-8005472844310.1038/ki.2011.217KimM.-G.Su BooC.Sook KoY.Young LeeH.Yong ChoW.Kyu KimH.JoS.-K.Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury2010259290829212-s2.0-7795625426810.1093/ndt/gfq183LeeS.HuenS.NishioH.NishioS.LeeH. K.ChoiB.-S.RuhrbergC.CantleyL. G.Distinct macrophage phenotypes contribute to kidney injury and repair20112223173262-s2.0-7955165468410.1681/ASN.2009060615ZhangM. Z.YaoB.YangS.CSF-1 signaling mediates recovery from acute kidney injury20121221245194532LechM.GröbmayrR.RyuM.Macrophage phenotype controls longterm AKI outcomes-kidney regeneration versus atrophyJournal of the American Society of Nephrology. In pressDehmelS.WangS.SchmidtC.KissE.LoeweR. P.ChillaS.SchlöndorffD.GröneH.-J.LuckowB.Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome20104012672782-s2.0-7424912196110.1002/eji.200939652DuffieldJ. S.ForbesS. J.ConstandinouC. M.ClayS.PartolinaM.VuthooriS.WuS.LangR.IredaleJ. P.Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair2005115156652-s2.0-1374425558910.1172/JCI200522675TamuraT.YanaiH.SavitskyD.TaniguchiT.The IRF family transcription factors in immunity and oncogenesis2008265355842-s2.0-4264911405910.1146/annurev.immunol.26.021607.090400EscalanteC. R.YieJ.ThanosD.AggarwalA. K.Structure of IRF-1 with bound DNA reveals determinants of interferon regulation199839166621031062-s2.0-003193364610.1038/34224LohoffM.MakT. W.Roles of interferon-regulatory factors in T-helper-cell differentiation2005521251352-s2.0-1344428346610.1038/nri1552TakaokaA.TamuraT.TaniguchiT.Interferon regulatory factor family of transcription factors and regulation of oncogenesis20082934674782-s2.0-3894921262610.1111/j.1349-7006.2007.00720.xMatsuyamaT.KimuraT.KitagawaM.PfefferK.KawakamiT.WatanabeN.KundigT. M.AmakawaR.KishiharaK.WakehamA.PotterJ.FurlongerC. L.NarendranA.SuzukiH.OhashiP. S.PaigeC. J.TaniguchiT.MakT. W.Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development199375183972-s2.0-002736146310.1016/0092-8674(93)90681-FMiyamotoM.FujitaT.KimuraY.MaruyamaM.HaradaH.SudoY.MiyataT.TaniguchiT.Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements19885469039132-s2.0-0023788435FujitaT.KimuraY.MiyamotoM.BarsoumianE. L.TaniguchiT.Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1198933762042702722-s2.0-0024546241MartinezF. O.GordonS.LocatiM.MantovaniA.Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression200617710730373112-s2.0-33750813483NegishiH.FujitaY.YanaiH.SakaguchiS.OuyangX.ShinoharaM.TakayanagiH.OhbaY.TaniguchiT.HondaK.Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program20061034115136151412-s2.0-3375006425910.1073/pnas.0607181103LiuJ.CaoS.HermanL. M.MaX.Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 120031988126512762-s2.0-014215674410.1084/jem.20030026LinR.HiscottJ.A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity19991911-21691802-s2.0-0033000436CareyM.The enhanceosome and transcriptional synergy1998921582-s2.0-003249823010.1016/S0092-8674(00)80893-4BlancoJ. C. G.ContursiC.SalkowskiC. A.DeWittD. L.OzatoK.VogelS. N.Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ- dependent cyclooxygenase 2 expression200019112213121442-s2.0-003468647110.1084/jem.191.12.2131SanceauJ.KaishoT.HiranoT.WietzerbinJ.Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and Sp1 transcription factors19952704627920279312-s2.0-002886577110.1074/jbc.270.46.27920NakagawaK.YokosawaH.PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-120025301–32042082-s2.0-003716385910.1016/S0014-5793(02)03486-5NhuM. Q.CuestaN.VogelS. N.Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2)20061252852952-s2.0-3424900448510.1177/09680519060120050401KamijoR.HaradaH.MatsuyamaT.BoslandM.GerecitanoJ.ShapiroD.LeJ.KohS. I.KimuraT.GreenS. J.MakT. W.TaniguchiT.VilčekJ.Requirement for transcription factor IRF-1 in NO synthase induction in macrophages19942635153161216152-s2.0-0028348307TakiS.SatoT.OgasawaraK.FukudaT.SatoM.HidaS.SuzukiG.MitsuyamaM.ShinE.-H.KojimaS.TaniguchiT.AsanoY.Multistage regulation of Th1-type immune responses by the transcription factor IRF-11997666736792-s2.0-003074143310.1016/S1074-7613(00)80443-4ElserB.LohoffM.KockS.GiaisiM.KirchhoffS.KrammerP. H.Li-WeberM.IFN-γ represses IL-4 expression via IRF-1 and IRF-220021767037122-s2.0-1874438609710.1016/S1074-7613(02)00471-5KhanI. A.MatsuuraT.FonsekaS.KasperL. H.Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- Mice199615626366432-s2.0-0030060390IadecolaC.SalkowskiC. A.ZhangF.AberT.NagayamaM.VogelS. N.RossM. E.The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury199918947197272-s2.0-003355735910.1084/jem.189.4.719WangY.JohnR.ChenJ.RichardsonJ. A.SheltonJ. M.BennettM.ZhouX. J.NagamiG. T.ZhangY.QingQ. W.LuC. Y.IRF-1 promotes inflammation early after ischemic acute kidney injury2009207154415552-s2.0-6764970312310.1681/ASN.2008080843HaradaH.FujitaT.MiyamotoM.KimuraY.MaruyamaM.FuriaA.MiyataT.TaniguchiT.Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes19895847297392-s2.0-0024380583CuestaN.SalkowskiC. A.ThomasK. E.VogelS. N.Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-21200317011573957472-s2.0-0038527326HanK.-J.JiangL.ShuH.-B.Regulation of IRF2 transcriptional activity by its sumoylation200837247727782-s2.0-4614909273010.1016/j.bbrc.2008.05.103CuestaN.NhuQ. M.ZudaireE.PolumuriS.CuttittaF.VogelS. N.IFN regulatory factor-2 regulates macrophage apoptosis through a STAT1/3- and caspase-1-dependent mechanism20071786360236112-s2.0-33947278297FehrT.SchoedonG.OdermattB.HoltschkeT.SchneemannM.BachmannM. F.MakT. W.HorakI.ZinkernagelR. M.Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis199718559219312-s2.0-003089666610.1084/jem.185.5.921SalkowskiC. A.BarberS. A.DetoreG. R.VogelS. N.Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes19961569310731102-s2.0-0029901302KluneJ. R.DhuparR.KimuraS.Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury20123035G666G673HidaS.OgasawaraK.SatoK.AbeM.TakayanagiH.YokochiT.SatoT.HiroseS.ShiraiT.TakiS.TaniguchiT.CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling20001356436552-s2.0-0033635304IchikawaE.HidaS.OmatsuY.ShimoyamaS.TakaharaK.MiyagawaS.InabaK.TakiS.Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2200410111390939142-s2.0-164229555710.1073/pnas.0400610101AuW.-C.MooreP. A.LowtherW.JuangY.-T.PithaP. M.Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes1995922511657116612-s2.0-002961869710.1073/pnas.92.25.11657NguyenH.HiscottJ.PithaP. M.The growing family of interferon regulatory factors1997842933122-s2.0-003141894410.1016/S1359-6101(97)00019-1YamamotoM.SatoS.HemmiH.HoshinoK.KaishoT.SanjoH.TakeuchiO.SugiyamaM.OkabeM.TakedaK.AkiraS.Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway200330156336406432-s2.0-004317628110.1126/science.1087262FitzgeraldK. A.RoweD. C.BarnesB. J.CaffreyD. R.VisintinA.LatzE.MonksB.PithaP. M.GolenbockD. T.LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF20031987104310552-s2.0-014195922410.1084/jem.20031023HondaK.TaniguchiT.IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors2006696446582-s2.0-3374805173810.1038/nri1900AkiraS.UematsuS.TakeuchiO.Pathogen recognition and innate immunity200612447838012-s2.0-3294446464810.1016/j.cell.2006.02.015IshikawaH.MaZ.BarberG. N.STING regulates intracellular DNA-mediated, type i interferon-dependent innate immunity200946172657887922-s2.0-7034994383410.1038/nature08476PanneD.ManiatisT.HarrisonS. C.An atomic model of the interferon-beta enhanceosome20071296111111232-s2.0-3425001796810.1016/j.cell.2007.05.019TakahasiK.SuzukiN. N.HoriuchiM.MoriM.SuharaW.OkabeY.FukuharaY.TerasawaH.AkiraS.FujitaT.InagakiF.X-ray crystal structure of IRF-3 and its functional implications200310119229272-s2.0-024265889510.1038/nsb1001PanneD.McWhirterS. M.ManiatisT.HarrisonS. C.Interferon regulatory factor 3 is regulated by a dual phosphorylation- dependent switch20072823122816228222-s2.0-3454793016310.1074/jbc.M703019200QinB. Y.LiuC.SrinathH.LamS. S.CorreiaJ. J.DerynckR.LinK.Crystal structure of IRF-3 in complex with CBP2005139126912772-s2.0-2434448741410.1016/j.str.2005.06.011ZhangM.TianY.WangR.-P.GaoD.ZhangY.DiaoF.-C.ChenD.-Y.ZhaiZ.-H.ShuH.-B.Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF320081811109611042-s2.0-5554914609110.1038/cr.2008.277FleetwoodA. J.DinhH.CookA. D.HertzogP. J.HamiltonJ. A.GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling20098624114212-s2.0-6944908510010.1189/jlb.1108702BiswasS. K.GangiL.PaulS.SchioppaT.SaccaniA.SironiM.BottazziB.DoniA.VincenzoB.PasqualiniF.VagoL.NebuloniM.MantovaniA.SicaA.A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)20061075211221222-s2.0-3334446003210.1182/blood-2005-01-0428TarassishinL.SuhH.-S.LeeS. C.Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway20118, article 1872-s2.0-8485517254910.1186/1742-2094-8-187LinR.HeylbroeckC.GeninP.PithaP. M.HiscottJ.Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription19991929599662-s2.0-0032926882EisenbeisC. F.SinghH.StorbU.Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator1995911137713872-s2.0-0029073345MittrückerH.-W.MatsuyamaT.GrossmanA.KündigT. M.PotterJ.ShahinianA.WakehamA.PattersonB.OhashiP. S.MakT. W.Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function199727552995405432-s2.0-1544434683410.1126/science.275.5299.540LawrenceT.NatoliG.Transcriptional regulation of macrophage polarization: enabling diversity with identity201111117507612-s2.0-8035514639910.1038/nri3088AhyiA.-N. N.ChangH.-C.DentA. L.NuttS. L.KaplanM. H.IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines20091833159816062-s2.0-6814912518810.4049/jimmunol.0803302HonmaK.UdonoH.KohnoT.YamamotoK.OgawaA.TakemoriT.KumatoriA.SuzukiS.MatsuyamaT.YuiK.Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macropages in response to LPS20051024416001160062-s2.0-2764455301110.1073/pnas.0504226102El ChartouniC.SchwarzfischerL.RehliM.Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming20102159-108218252-s2.0-7795542682110.1016/j.imbio.2010.05.031SatohT.TakeuchiO.VandenbonA.YasudaK.TanakaY.KumagaiY.MiyakeT.MatsushitaK.OkazakiT.SaitohT.HonmaK.MatsuyamaT.YuiK.TsujimuraT.StandleyD. M.NakanishiK.NakaiK.AkiraS.The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection201011109369442-s2.0-7795695419710.1038/ni.1920IshiiM.WenH.CorsaC. A. S.LiuT.CoelhoA. L.AllenR. M.CarsonW. F.IVCavassaniK. A.LiX.LukacsN. W.HogaboamC. M.DouY.KunkelS. L.Epigenetic regulation of the alternatively activated macrophage phenotype200911415324432542-s2.0-7035043596210.1182/blood-2009-04-217620TakaokaA.YanaiH.KondoS.DuncanG.NegishiH.MizutaniT.KanoS.-I.HondaK.OhbaY.MakT. W.TaniguchiT.Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors200543470302432492-s2.0-1504434546110.1038/nature03308PaunA.BankotiR.JoshiT.PithaP. M.StägerS.Critical role of IRF-5 in the development of t helper 1 responses to Leishmania donovani infection2011712-s2.0-7955150896310.1371/journal.ppat.1001246e1001246SavitskyD. A.YanaiH.TamuraT.TaniguchiT.HondaK.Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus20101072210154101592-s2.0-7795336834710.1073/pnas.1005599107LaceyD. C.AchuthanA.FleetwoodA. J.DinhH.RoiniotisJ.ScholzG. M.ChangM. W.BeckmanS. K.CookA. D.HamiltonJ. A.Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models20121881157525765EamesH. L.SalibaD. G.KrausgruberT.LanfrancottiA.RyzhakovG.UdalovaI. A.KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages20122171213151324KrausgruberT.BlazekK.SmallieT.AlzabinS.LockstoneH.SahgalN.HussellT.FeldmannM.UdalovaI. A.IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses20111232312382-s2.0-7995167151010.1038/ni.1990HedlM.AbrahamC.IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells20121881153485356FengD.StoneR. C.ElorantaM.-L.Sangster-GuityN.NordmarkG.SigurdssonS.WangC.AlmG.SyvänenA.-C.RönnblomL.BarnesB. J.Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus20106225625732-s2.0-7574915330110.1002/art.27223GrahamR. R.KyogokuC.SigurdssonS.VlasovaI. A.DaviesL. R. L.BaechlerE. C.PlengeR. M.KoeuthT.OrtmannW. A.HomG.BauerJ. W.GillettC.BurttN.GrahamD. S. C.OnofrioR.PetriM.GunnarssonI.SvenungssonE.RönnblomL.NordmarkG.GregersenP. K.MoserK.GaffneyP. M.CriswellL. A.VyseT. J.SyvänenA.-C.BohjanenP. R.DalyM. J.BehrensT. W.AltshulerD.Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus200710416675867632-s2.0-3424986040810.1073/pnas.0701266104StoneR. C.FengD.DengJ.SinghS.YangL.Fitzgerald-BocarslyP.ElorantaM.-L.RönnblomL.BarnesB. J.Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type i interferons20126437887982-s2.0-8485778000310.1002/art.33395ZuccheroT. M.CooperM. E.MaherB. S.Daack-HirschS.NepomucenoB.RibeiroL.CaprauD.ChristensenK.SuzukiY.MachidaJ.NatsumeN.YoshiuraK.-I.VieiraA. R.OrioliI. M.CastillaE. E.MorenoL.Arcos-BurgosM.LidralA. C.FieldL. L.LiuY.-E.RayA.GoldsteinT. H.SchultzR. E.ShiM.JohnsonM. K.KondoS.SchutteB. C.MarazitaM. L.MurrayJ. C.Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate200435187697802-s2.0-414311580910.1056/NEJMoa032909IngrahamC. R.KinoshitaA.KondoS.YangB.SajanS.TroutK. J.MalikM. I.DunnwaldM.GoudyS. L.LovettM.MurrayJ. C.SchutteB. C.Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)20063811133513402-s2.0-3375045233910.1038/ng1903SatoM.SuemoriH.HataN.AsagiriM.OgasawaraK.NakaoK.NakayaT.KatsukiM.NoguchiS.TanakaN.TaniguchiT.Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction20001345395482-s2.0-0033680737SatoM.HataN.AsagiriM.NakayaT.TaniguchiT.TanakaN.Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7199844111061102-s2.0-003243492410.1016/S0014-5793(98)01514-2QiC.-F.LiZ.RaffeldM.WangH.KovalchukA. L.MorseH. C.IIIDifferential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments200945162742-s2.0-7034974873810.1007/s12026-008-8032-2WangH.MorseH. C.IIIIRF8 regulates myeloid and B lymphoid lineage diversification2009431–31091172-s2.0-6654912597710.1007/s12026-008-8055-8BeckerA. M.MichaelD. G.SatpathyA. T.SciammasR.SinghH.BhattacharyaD.IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors20121199200320122-s2.0-8485772487710.1182/blood-2011-06-364976Laricchia-RobbioL.TamuraT.KarpovaT.SpragueB. L.McNallyJ. G.OzatoK.Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages20051024014368143732-s2.0-2644449060710.1073/pnas.0504014102HoltschkeT.LöhlerJ.KannoY.FehrT.GieseN.RosenbauerF.LouJ.KnobelochK.-P.GabrieleL.WaringJ. F.BachmannM. F.ZinkernagelR. M.MorseH. C.IIIOzatoK.HorakI.Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene19968723073172-s2.0-1604436970910.1016/S0092-8674(00)81348-3XuH.ZhuJ.SmithS.Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization2012137642650ChangT. H.XuS.TailorP.KannoT.OzatoK.The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation2012189735483556ReichN. C.LiuL.Tracking STAT nuclear traffic2006686026122-s2.0-3374657064710.1038/nri1885